Annual Accounts Payable
$8.60 M
+$107.00 K+1.26%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual accounts payable is $8.60 million, with the most recent change of +$107.00 thousand (+1.26%) on December 31, 2023.
- During the last 3 years, XENE annual accounts payable has risen by +$5.56 million (+182.74%).
- XENE annual accounts payable is now at all-time high.
Performance
XENE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.42 M
-$4.07 M-42.88%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly accounts payable is $5.42 million, with the most recent change of -$4.07 million (-42.88%) on September 30, 2024.
- Over the past year, XENE quarterly accounts payable has dropped by -$4.07 million (-42.88%).
- XENE quarterly accounts payable is now -54.89% below its all-time high of $12.03 million, reached on June 30, 2023.
Performance
XENE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
XENE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.3% | -42.9% |
| 3 y3 years | +182.7% | -54.9% |
| 5 y5 years | +1192.9% | -54.9% |
XENE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.8% | -54.9% | +227.0% |
| 5 y | 5-year | at high | +247.7% | -54.9% | +232.2% |
| alltime | all time | at high | +2099.0% | -54.9% | +1287.5% |
Xenon Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.42 M(-42.9%) |
| Jun 2024 | - | $9.50 M(+47.7%) |
| Mar 2024 | - | $6.43 M(-25.2%) |
| Dec 2023 | $8.60 M(+1.3%) | $8.60 M(+41.0%) |
| Sep 2023 | - | $6.10 M(-49.3%) |
| Jun 2023 | - | $12.03 M(+5.4%) |
| Mar 2023 | - | $11.41 M(+34.4%) |
| Dec 2022 | $8.49 M(+122.0%) | $8.49 M(+175.5%) |
| Sep 2022 | - | $3.08 M(-3.0%) |
| Jun 2022 | - | $3.18 M(+91.6%) |
| Mar 2022 | - | $1.66 M(-56.6%) |
| Dec 2021 | $3.82 M(+25.7%) | $3.82 M(+24.0%) |
| Sep 2021 | - | $3.08 M(-5.9%) |
| Jun 2021 | - | $3.28 M(+53.8%) |
| Mar 2021 | - | $2.13 M(-29.9%) |
| Dec 2020 | $3.04 M(+23.0%) | $3.04 M(+38.4%) |
| Sep 2020 | - | $2.20 M(+34.6%) |
| Jun 2020 | - | $1.63 M(-49.2%) |
| Mar 2020 | - | $3.22 M(+30.1%) |
| Dec 2019 | $2.47 M | $2.47 M(+80.4%) |
| Sep 2019 | - | $1.37 M(-8.5%) |
| Jun 2019 | - | $1.50 M(+39.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $1.07 M(+61.1%) |
| Dec 2018 | $665.00 K(-46.9%) | $665.00 K(-30.7%) |
| Sep 2018 | - | $959.00 K(+12.4%) |
| Jun 2018 | - | $853.00 K(+80.3%) |
| Mar 2018 | - | $473.00 K(-62.3%) |
| Dec 2017 | $1.25 M(-14.4%) | $1.25 M(+54.9%) |
| Sep 2017 | - | $809.00 K(-38.4%) |
| Jun 2017 | - | $1.31 M(+12.8%) |
| Mar 2017 | - | $1.17 M(-20.4%) |
| Dec 2016 | $1.46 M(+34.5%) | $1.46 M(+185.7%) |
| Sep 2016 | - | $512.00 K(-21.8%) |
| Jun 2016 | - | $655.00 K(-36.0%) |
| Mar 2016 | - | $1.02 M(-6.0%) |
| Dec 2015 | $1.09 M(+96.7%) | $1.09 M(+33.2%) |
| Sep 2015 | - | $817.00 K(-6.3%) |
| Jun 2015 | - | $872.00 K(+38.0%) |
| Mar 2015 | - | $632.00 K(+14.3%) |
| Dec 2014 | $553.00 K(+41.4%) | $553.00 K(+8.2%) |
| Sep 2014 | - | $511.00 K(-17.6%) |
| Jun 2014 | - | $620.00 K(+58.6%) |
| Dec 2013 | $391.00 K(-52.4%) | $391.00 K |
| Dec 2012 | $821.00 K | - |
FAQ
- What is Xenon Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual accounts payable year-on-year change?
- What is Xenon Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly accounts payable year-on-year change?
What is Xenon Pharmaceuticals annual accounts payable?
The current annual accounts payable of XENE is $8.60 M
What is the all time high annual accounts payable for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual accounts payable is $8.60 M
What is Xenon Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, XENE annual accounts payable has changed by +$107.00 K (+1.26%)
What is Xenon Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of XENE is $5.42 M
What is the all time high quarterly accounts payable for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly accounts payable is $12.03 M
What is Xenon Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, XENE quarterly accounts payable has changed by -$4.07 M (-42.88%)